Sulesomab Biosimilar - Research Grade

Human

NCA-90

5mg/ml

Fab' - G1 - nd

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

NCA-90 (CD66c) is a granulocyte surface antigen used as a marker for imaging and targeting infection and inflammation in research. This product is a research-grade, unconjugated analog of sulesomab, supplied as a recombinant Fab' fragment directed against NCA-90, for research use only. It is manufactured to in vivo standards in a low-endotoxin format and made in scalable milligram to gram quantities for high-throughput laboratories. The fragment suits granulocyte-targeting functional assays, in vitro binding screens, and in vivo models of infection and inflammation localization. Reliable batch-to-batch consistency helps standardize comparisons across in vitro and in vivo experiments.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks